Active Ingredient: DIPHENHYDRAMINE HYDROCHLORIDE; NAPROXEN SODIUM
Proprietary Name: NAPROXEN SODIUM AND DIPHENHYDRAMINE HYDROCHLORIDE
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 25MG;220MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A209726
Product Number: 001
Approval Date: Oct 23, 2018
Applicant Holder Full Name: AMNEAL PHARMACEUTICALS CO GMBH
Marketing Status:
Over-the-counter
Patent and Exclusivity Information